FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2980491069> ?p ?o ?g. }

• W2980491069 endingPage "8" @default.
• W2980491069 startingPage "1" @default.
• W2980491069 abstract "There is evidence to support use of external beam radiotherapy (EBRT) in combination with both low dose rate brachytherapy (LDR-EBRT) and high dose rate brachytherapy (HDR-EBRT) to treat intermediate and high risk prostate cancer.Men with intermediate and high risk prostate cancer treated using LDR-EBRT (treated between 1996 and 2007) and HDR-EBRT (treated between 2007 and 2012) were identified from an institutional database. Multivariable analysis was performed to evaluate the relationship between patient, disease and treatment factors with biochemical progression free survival (bPFS).116 men were treated with LDR-EBRT and 171 were treated with HDR-EBRT. At 5 years, bPFS was estimated to be 90.5% for the LDR-EBRT cohort and 77.6% for the HDR-EBRT cohort. On multivariable analysis, patients treated with HDR-EBRT were more than twice as likely to experience biochemical progression compared with LDR-EBRT (HR 2.33, 95% CI 1.12-4.07). Patients with Gleason ≥8 disease were more than five times more likely to experience biochemical progression compared with Gleason 6 disease (HR 5.47, 95% CI 1.26-23.64). Cumulative incidence of ≥grade 3 genitourinary and gastrointestinal toxicities for the LDR-EBRT and HDR-EBRT cohorts were 8% versus 4% and 5% versus 1% respectively, although these differences did not reach statistical significance.LDR-EBRT may provide more effective PSA control at 5 years compared with HDR-EBRT. Direct comparison of these treatments through randomised trials are recommended to investigate this hypothesis further." @default.
• W2980491069 created "2019-10-25" @default.
• W2980491069 creator A5003485791 @default.
• W2980491069 creator A5006872888 @default.
• W2980491069 creator A5011571875 @default.
• W2980491069 creator A5028317483 @default.
• W2980491069 creator A5048070921 @default.
• W2980491069 creator A5054091749 @default.
• W2980491069 creator A5056575468 @default.
• W2980491069 creator A5059992220 @default.
• W2980491069 creator A5075696413 @default.
• W2980491069 creator A5075796933 @default.
• W2980491069 creator A5078894373 @default.
• W2980491069 creator A5089586523 @default.
• W2980491069 creator A5089818936 @default.
• W2980491069 date "2020-01-01" @default.
• W2980491069 modified "2023-10-16" @default.
• W2980491069 title "A comparison of outcomes for patients with intermediate and high risk prostate cancer treated with low dose rate and high dose rate brachytherapy in combination with external beam radiotherapy" @default.
• W2980491069 cites W1926020851 @default.
• W2980491069 cites W1965536955 @default.
• W2980491069 cites W1983129876 @default.
• W2980491069 cites W2012580954 @default.
• W2980491069 cites W2015399916 @default.
• W2980491069 cites W2016749608 @default.
• W2980491069 cites W2033484407 @default.
• W2980491069 cites W2037565714 @default.
• W2980491069 cites W2047608066 @default.
• W2980491069 cites W2047912614 @default.
• W2980491069 cites W2048239925 @default.
• W2980491069 cites W2049677718 @default.
• W2980491069 cites W2057408444 @default.
• W2980491069 cites W2062313368 @default.
• W2980491069 cites W2063754698 @default.
• W2980491069 cites W2076303343 @default.
• W2980491069 cites W2090136421 @default.
• W2980491069 cites W2092411758 @default.
• W2980491069 cites W2114221591 @default.
• W2980491069 cites W2121407352 @default.
• W2980491069 cites W2135257055 @default.
• W2980491069 cites W2141944007 @default.
• W2980491069 cites W2157634805 @default.
• W2980491069 cites W2473382228 @default.
• W2980491069 cites W2553678345 @default.
• W2980491069 cites W2569728867 @default.
• W2980491069 cites W2586272675 @default.
• W2980491069 cites W2613454452 @default.
• W2980491069 cites W2716892249 @default.
• W2980491069 cites W2889865404 @default.
• W2980491069 cites W2899946269 @default.
• W2980491069 cites W2909748057 @default.
• W2980491069 doi "https://doi.org/10.1016/j.ctro.2019.10.001" @default.
• W2980491069 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6831705" @default.
• W2980491069 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31701035" @default.
• W2980491069 hasPublicationYear "2020" @default.
• W2980491069 type Work @default.
• W2980491069 sameAs 2980491069 @default.
• W2980491069 citedByCount "10" @default.
• W2980491069 countsByYear W29804910692020 @default.
• W2980491069 countsByYear W29804910692021 @default.
• W2980491069 countsByYear W29804910692022 @default.
• W2980491069 countsByYear W29804910692023 @default.
• W2980491069 crossrefType "journal-article" @default.
• W2980491069 hasAuthorship W2980491069A5003485791 @default.
• W2980491069 hasAuthorship W2980491069A5006872888 @default.
• W2980491069 hasAuthorship W2980491069A5011571875 @default.
• W2980491069 hasAuthorship W2980491069A5028317483 @default.
• W2980491069 hasAuthorship W2980491069A5048070921 @default.
• W2980491069 hasAuthorship W2980491069A5054091749 @default.
• W2980491069 hasAuthorship W2980491069A5056575468 @default.
• W2980491069 hasAuthorship W2980491069A5059992220 @default.
• W2980491069 hasAuthorship W2980491069A5075696413 @default.
• W2980491069 hasAuthorship W2980491069A5075796933 @default.
• W2980491069 hasAuthorship W2980491069A5078894373 @default.
• W2980491069 hasAuthorship W2980491069A5089586523 @default.
• W2980491069 hasAuthorship W2980491069A5089818936 @default.
• W2980491069 hasBestOaLocation W29804910691 @default.
• W2980491069 hasConcept C121608353 @default.
• W2980491069 hasConcept C126322002 @default.
• W2980491069 hasConcept C126894567 @default.
• W2980491069 hasConcept C133507102 @default.
• W2980491069 hasConcept C141071460 @default.
• W2980491069 hasConcept C143998085 @default.
• W2980491069 hasConcept C2775908122 @default.
• W2980491069 hasConcept C2776235491 @default.
• W2980491069 hasConcept C2777416452 @default.
• W2980491069 hasConcept C2780192828 @default.
• W2980491069 hasConcept C3020003399 @default.
• W2980491069 hasConcept C509974204 @default.
• W2980491069 hasConcept C71924100 @default.
• W2980491069 hasConcept C72563966 @default.
• W2980491069 hasConcept C88879693 @default.
• W2980491069 hasConceptScore W2980491069C121608353 @default.
• W2980491069 hasConceptScore W2980491069C126322002 @default.
• W2980491069 hasConceptScore W2980491069C126894567 @default.
• W2980491069 hasConceptScore W2980491069C133507102 @default.
• W2980491069 hasConceptScore W2980491069C141071460 @default.
• W2980491069 hasConceptScore W2980491069C143998085 @default.
• W2980491069 hasConceptScore W2980491069C2775908122 @default.

• next